K. Suzumura

发表

Fluvastatin depresses the enhanced lipid peroxidation in vitamin E-deficient hamsters

N. Ohashi, H. Narita, M. Yasuhara, 2001, Free radical research.

Antioxidative property of T-0970, a new ureidophenol derivative

H. Kubota, H. Ohmizu, T. Suzuki, 2000, Free radical research.

An in vitro study of the hydroxyl radical scavenging property of fluvastatin, and HMG-CoA reductase inhibitor.

M. Yasuhara, A. Odawara, K. Tanaka, 1999, Chemical & pharmaceutical bulletin.

Superoxide anion scavenging properties of fluvastatin and its metabolites.

M. Yasuhara, K. Suzumura, H. Narita, 1999, Chemical & pharmaceutical bulletin.

Inhibitory effects of fluvastatin and its metabolites on hydrogen peroxide-induced oxidative destruction of hemin and low-density lipoprotein.

M. Yasuhara, K. Tanaka, K. Suzumura, 2000, Biological & pharmaceutical bulletin.

Decreased turnovers of glutathione and ascorbic acid in watanabe heritable hyperlipidemic rabbits.

E. Kasahara, M. Inoue, K. Suzumura, 2000, Journal of nutritional science and vitaminology.

Fluvastatin Normalizes The Decreased Turnovers Of Glutathione And Ascorbic Acid In Watanabe Heritable Hyperlipidaemic Rabbits

E. Kasahara, M. Inoue, Y. Ohnishi, 2000, Clinical and experimental pharmacology & physiology.

Protective effect of TA-993, a novel therapeutic agent for peripheral circulatory insufficiency, on skeletal muscle fatigue in a rat model of hindlimb ischemia.

H. Inoue, H. Narita, H. Doi, 2000, Japanese journal of pharmacology.

Pharmacologically Active Components of Viticis Fructus (Vitex rotundifolia). I. The Components Having Vascular Relaxation Effects

E. Okuyama, M. Yamazaki, K. Suzumura, 1998 .

Pharmacologically active components of Todopon Puok (Fagraea racemosa), a medicinal plant from Borneo.

E. Okuyama, M. Yamazaki, K. Suzumura, 1995, Chemical & pharmaceutical bulletin.

Protective effect of fluvastatin sodium (XU-62-320), a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, on oxidative modification of human low-density lipoprotein in vitro.

M. Yasuhara, K. Tanaka, T. Suzuki, 1999, Biochemical pharmacology.

Effects of fluvastatin and its major metabolites on low-density lipoprotein oxidation and cholesterol esterification in macrophages.

H. Narita, M. Yasuhara, K. Tanaka, 2001, Japanese journal of pharmacology.

Turnover of Glutathione and Ascorbic Acid is Suppressed in Hyperlipidemic Rabbits

E. Kasahara, M. Inoue, K. Suzumura, 2000 .

Antioxidants Suppress Plasma Levels of Lectinlike Oxidized Low-Density Lipoprotein Receptor-Ligands and Reduce Atherosclerosis in Watanabe Heritable Hyperlipidemic Rabbits

T. Sawamura, M. Yasuhara, K. Suzumura, 2006, Journal of cardiovascular pharmacology.

Fluvastatin, an HMG-CoA reductase inhibitor, protects LDL from oxidative modification in hypercholesterolemic rabbits.

M. Yasuhara, A. Odawara, K. Tanaka, 2000, Biological & pharmaceutical bulletin.

In vitro inhibitory effects of the optical isomers and metabolites of fluvastatin on copper ion-induced LDL oxidation.

M. Yasuhara, A. Odawara, K. Tanaka, 1999, Biological and Pharmaceutical Bulletin.